Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Annals of Neurology|October 1, 1987
Does papaverine interact with levodopa in Parkinson's disease?J L Montastruc, O Rascol, J Belin, et al.
Fundamental & Clinical Pharmacology|January 1, 1994
Drug-induced parkinsonism: a reviewJ L Montastruc, M E Llau, O Rascol, et al.
Journal of the Neurological Sciences|November 1, 1994
A single report of hemiplegic arm stretching related to yawning: further investigation using apomorphine administrationO Blin, O Rascol, J P Azulay, et al.
Drugs & Aging|August 3, 2001
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and managementJ M Senard, C Brefel-Courbon, O Rascol, et al.
Journal Francais D'Ophtalmologie|January 1, 1985
[Ocular motility and the cerebellum]O Rascol, M Clanet, T Venisse, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?J L Montastruc, O Rascol, J M Senard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphanJ L Montastruc, N Fabre, O Rascol, et al.
European Journal of Neurology|June 26, 2018
Experience of care for Parkinson's disease in European countries: a survey by the European Parkinson's Disease AssociationA Schrag, K Khan, S Hotham, et al.
Revue Neurologique|January 1, 1993
[Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]J M Senard, O Rascol, B Chamontin, et al.
La Revue Du Praticien|May 15, 1997
[Movement disorders of drug origin]J L Montastruc, M E Llau-Bousquet, J M Senard, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Annals of Neurology|October 1, 1987
Does papaverine interact with levodopa in Parkinson's disease?J L Montastruc, O Rascol, J Belin, et al.
Fundamental & Clinical Pharmacology|January 1, 1994
Drug-induced parkinsonism: a reviewJ L Montastruc, M E Llau, O Rascol, et al.
Journal of the Neurological Sciences|November 1, 1994
A single report of hemiplegic arm stretching related to yawning: further investigation using apomorphine administrationO Blin, O Rascol, J P Azulay, et al.
Drugs & Aging|August 3, 2001
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and managementJ M Senard, C Brefel-Courbon, O Rascol, et al.
Journal Francais D'Ophtalmologie|January 1, 1985
[Ocular motility and the cerebellum]O Rascol, M Clanet, T Venisse, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?J L Montastruc, O Rascol, J M Senard, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphanJ L Montastruc, N Fabre, O Rascol, et al.
European Journal of Neurology|June 26, 2018
Experience of care for Parkinson's disease in European countries: a survey by the European Parkinson's Disease AssociationA Schrag, K Khan, S Hotham, et al.
Revue Neurologique|January 1, 1993
[Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]J M Senard, O Rascol, B Chamontin, et al.
La Revue Du Praticien|May 15, 1997
[Movement disorders of drug origin]J L Montastruc, M E Llau-Bousquet, J M Senard, et al.
Pageof 22